Nano+™ Polymer-free Sirolimus-eluting Coronary Stent System
Nano+™ Polymer Free Drug Eluting StentsSystem Details
Product Description
- Nanoporous cavities on strut abluminal surface functioning as drug carrier to ensure the firm adhesion.
- Vacuum drug coating technology ensures complete drug dosage and coating stability.
- Post-treatment after drug loading helps with sustained drug release.
- Soft tapered tip provides smooth transition from guidewire to balloon catheter and excellent crossability.
- Short shoulder design at both ends of the balloon ensures the accurate dilation to the lesion, and reduces the damage to normal vessel next to the lesion.
- Patented hydrophilic coating on distal shaft provides outstanding pushability.
- Polymer-free design significantly reduces the inflammatory response after stent implantation to guarantee the long-term safety.
- Polymer-free design facilitates earlier endothelialization which significantly shorten the DAPT time.
- The rough strut surface helps with earlier and easier endothelialization to reduce the risk of thrombosis.
DES Efficacy [1]
BMS Safety [2]
Nano+™ OCT Study
An OCT Study in Europe Shows Nano+™ A Great Combination of DES Efficacy and BMS Safety
Prouduct Features
- Polymer-free DES
- Nanoporous drug carrier on abluminal surface
- Balanced strut thickness
- High radial force
- Sine wave + 3-3-3 link
- Double helix structure
- Large open cell
- Precise positioning markers
- Effective drug of Sirolimus
- Vacuum drug coating technology
- 90-day drug releasing period
- New delivery system
Prouduct Benefits
- Significantly shorten DAPT time
- Earlier & better endothelialization
- Highly reduced risk of thrombosis
- Great deliverability
- Easy positioning and placement
- Optimal tissue scaffolding
- Excellent side branch access
- Scientific drug releasing period
Prouduct Ranges
- Ø 2.5 - 4.0 mm
- 12 - 36 mm multi stent lengths
Clinical Studies
An OCT Study in Europe Shows Nano+™ A Great Combination of DES Efficacy and BMS Safety [3].
In a prospective, multicentre, single-arm, open-label study, OCT examinations
were performed at three months in 45 patients (47 lesions). 23 patients with 24 lesions
had serial coronary angiography and OCT assessment at three and six months.
OCT Analyses
Coverage status of the individual stents/patients at two time points (three and six months).
Serial OCT showed almost complete vascular healing at six months, even when coverage was insufficient at three months. This suggests an adequate safety and efficacy profile of the device at that point in time.
Specifications
Technical Parameters |
|
Stent Material |
316L Stainless Steel |
Strut Design |
Nanoporous drug carrier on abluminal surface |
Metal to Artery Ratio |
15% |
Recoil |
< 2% |
Shortening |
< 1% |
Crossing Profile |
Ordering Information
Stent Diameter |
Stent Length (mm) |
|||||||
(mm) |
12 |
15 |
18 |
21 |
24 |
29 |
33 |
36 |
LPRPS2512 |
LPRPS2515 |
LPRPS2518 |
LPRPS2521 |
LPRPS2524 |
LPRPS2529 |
LPRPS2533 |
- |
|
LPRPS2712 |
LPRPS2715 |
LPRPS2718 |
LPRPS2721 |
LPRPS2724 |
LPRPS2729 |
LPRPS2733 |
LPRPS2736 |
|
3 |
LPRPS3012 |
LPRPS3015 |
LPRPS3018 |
LPRPS3021 |
LPRPS3024 |
LPRPS3029 |
LPRPS3033 |
LPRPS3036 |
LPRPS3512 |
LPRPS3515 |
LPRPS3518 |
LPRPS3521 |
LPRPS3524 |
LPRPS3529 |
LPRPS3533 |
LPRPS3536 |
|
4 |
LPRPS4012 |
LPRPS4015 |
LPRPS4018 |
LPRPS4021 |
LPRPS4024 |
LPRPS4029 |
LPRPS4033 |
LPRPS4036 |
Provide Comprehensive Solution For
Global Patients
Fill out the form to leave inquiries. We would get back to you as soon as possible.
As one of professional medical device manufacturers in China, we have been engaged in manufacturing medical device for many years. Thus, we have confidence to benefit the people in needs through our products.
Отправить запрос, связаться с поставщиком
Другие товары поставщика
MemoPart™ Patent Ductus Arteriosus (PDA) Occluder | MemoPart™ Multiple designs, anastomosing lesions MemoPart™ Patent Ductus Arteriosus (PDA) Occluder Details Product Description MemoP... | |
PC-60A Fingertip Oximeter | Features Measuring SpO2, PR with Pulse bar Special design with splash-proof and drop-resistant Audible alarm with low battery indication 2 direc... | |
PC-1000 Central Monitoring Station | Central Monitoring Station Up to 64-bed monitoring with single and dual display LAN and wireless connections are available Large storage capacity f... | |
LF05A Oxygen Generator | Large-screen display Built-in water tank Remote control With an atomizing function Up to 11 alarm items Hidden oxygen/atomizing nozz... | |
Pazopanib | LepuMedical Technology ( Beijing ) Co., Ltd is a professional pazopanib manufacturer, we provide lepu thermometer, nebulizer machine for kids, ruca... |
Похожие товары
Spectinomycin Hydrochloride Soluble Powder 50% 200g | Продавец: Hebei Shengxue Dacheng Pharmaceutical Co., Ltd. | Product Name: Spectinomycin Hydrochloride Soluble PowderMain ingredients: Spectinomycin hydrochlo... | |
Spectinomycin Hydrochloride and Lincomycin Hydrochloride Soluble Powder 10% 200g | Продавец: Hebei Shengxue Dacheng Pharmaceutical Co., Ltd. | Product Name: Spectinomycin Hydrochloride and Lincomycin Hydrochloride Soluble PowderMain Ingredi... | |
Spectinomycin Hydrochloride and Lincomycin Hydrochloride Soluble Powder 10% 500g | Продавец: Hebei Shengxue Dacheng Pharmaceutical Co., Ltd. | Product Name: Spectinomycin Hydrochloride and Lincomycin Hydrochloride Soluble PowderMain Ingredi... | |
Sulfamonomethoxine Sodium Soluble Powder 10% 500g | Продавец: Hebei Shengxue Dacheng Pharmaceutical Co., Ltd. | Brand Name: Shengxue Qiu KangGeneric Name: Sulfamonomethoxine Sodium Soluble PowderActive Ingredi... | |
Sulfachloropyrazine Sodium Soluble Powder | Продавец: Hebei Shengxue Dacheng Pharmaceutical Co., Ltd. | Trade Name: Shengxue Qiuling Common Name: Sulfachloropyrazine Sodium Soluble Powder Main Ingredie... |